IRB Barcelona receives the support of the ERC to develop a test to predict metastasis of colon and liver cancer
Read moreImmune cells may be responsible for drug resistance in melanoma patients, according to research published in Cancer Discovery.
Read moreKeck Medicine of USC scientists have discovered new clues about a drug instrumental in treating a certain blood cancer that may provide important targets for researchers searching for cures.
Read moreMaintaining the ends of chromosomes, called telomeres, is a requisite feature of cells that are able to continuously divide and also a hallmark of human cancer.
Read moreIncreased expression of extracellular matrix genes could be a novel therapeutic target
Read moreScientists at the University of York are working on a promising new approach for tackling colorectal cancer, the second most common cause of cancer-related death
Read moreSalk scientists find that a vitamin D-derivative makes tumors vulnerable to chemotherapy
Read moreLos expertos consideran que la autofluorescencia podría impulsar la medicina personalizada del futuro y el desarrollo de tratamientos oncológicos más eficaces
Read moreLevels of caveolin-1 in alveolar rhabdomyosracoma are undetectable or very low and that genetic reintroduction and restatement by epigenetic drugs, slows the growth of these tumors
Read moreUna combinación de fármacos prolonga la supervivencia en tumor de mama HER2-positivo mestásico a las 56,5 meses
Read moreCientíficos españoles han definido una interacción entre proteínas clave para la división de las células. Los resultados podrían ayudar a mejorar las terapias oncológicas dirigidas a bloquear ...
Read moreAsegura el Dr. Ignacio Melero, investigador del CIMA y de la Clínica Universidad de Navarra, que ha participado en una sesión presidencial del Congreso de la Sociedad Europea de Oncología Médica
Read more